Medical Care
Global Microbiome Therapeutics Market Research Report 2024
- Jan 26, 24
- ID: 39361
- Pages: 107
- Figures: 222
- Views: 21
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The global Microbiome Therapeutics market was valued at US$ 91 million in 2023 and is anticipated to reach US$ 892.2 million by 2030, witnessing a CAGR of 38.1% during the forecast period 2024-2030.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI is about 52%.
For Microbiome Therapeutics Pipeline Product, SER-109, ABI-H0731, ribaxamase, SYN-010 have the most investment in research, there are in Phase 3, PHASE 1b and Phase 2.
North American is the largest market, It occupy nearly 37% market share. Following North American, Europe is the second largest market with the consumption market share of 30%.
Market competition is not intense. Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech are the leading Developers in the industry, with about 60% market shares.
This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics.
Report Scope
The Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Segment by Type
Upper GIT
Lower GIT
Segment by Application
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The global Microbiome Therapeutics market was valued at US$ 91 million in 2023 and is anticipated to reach US$ 892.2 million by 2030, witnessing a CAGR of 38.1% during the forecast period 2024-2030.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI is about 52%.
For Microbiome Therapeutics Pipeline Product, SER-109, ABI-H0731, ribaxamase, SYN-010 have the most investment in research, there are in Phase 3, PHASE 1b and Phase 2.
North American is the largest market, It occupy nearly 37% market share. Following North American, Europe is the second largest market with the consumption market share of 30%.
Market competition is not intense. Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech are the leading Developers in the industry, with about 60% market shares.
This report aims to provide a comprehensive presentation of the global market for Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapeutics.
Report Scope
The Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Segment by Type
Upper GIT
Lower GIT
Segment by Application
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market by Application
1.3.1 Global Microbiome Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Orphan Drug
1.3.5 Immuno-oncology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapeutics Market Perspective (2019-2030)
2.2 Microbiome Therapeutics Growth Trends by Region
2.2.1 Global Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbiome Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Microbiome Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Microbiome Therapeutics Market Dynamics
2.3.1 Microbiome Therapeutics Industry Trends
2.3.2 Microbiome Therapeutics Market Drivers
2.3.3 Microbiome Therapeutics Market Challenges
2.3.4 Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue
3.4 Global Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2023
3.5 Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapeutics Breakdown Data by Type
4.1 Global Microbiome Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2025-2030)
5 Microbiome Therapeutics Breakdown Data by Application
5.1 Global Microbiome Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microbiome Therapeutics Market Size (2019-2030)
6.2 North America Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbiome Therapeutics Market Size by Country (2019-2024)
6.4 North America Microbiome Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiome Therapeutics Market Size (2019-2030)
7.2 Europe Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
7.4 Europe Microbiome Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Microbiome Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbiome Therapeutics Market Size (2019-2030)
9.2 Latin America Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbiome Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Microbiome Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Detail
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2019-2024)
11.1.5 Seres Therapeutics Recent Development
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Detail
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2019-2024)
11.2.5 Assembly Biosciences Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Detail
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2019-2024)
11.3.5 Synthetic Biologics Recent Development
11.4 Interxon
11.4.1 Interxon Company Detail
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Therapeutics Introduction
11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2019-2024)
11.4.5 Interxon Recent Development
11.5 PureTech
11.5.1 PureTech Company Detail
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Therapeutics Introduction
11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2019-2024)
11.5.5 PureTech Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Detail
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Therapeutics Introduction
11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2019-2024)
11.6.5 Synlogic Recent Development
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Detail
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Therapeutics Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2019-2024)
11.7.5 Enterome BioScience Recent Development
11.8 4D Pharma
11.8.1 4D Pharma Company Detail
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Therapeutics Introduction
11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2019-2024)
11.8.5 4D Pharma Recent Development
11.9 Second Genome
11.9.1 Second Genome Company Detail
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Therapeutics Introduction
11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2019-2024)
11.9.5 Second Genome Recent Development
11.10 AOBiome
11.10.1 AOBiome Company Detail
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Therapeutics Introduction
11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2019-2024)
11.10.5 AOBiome Recent Development
11.11 C3 Jian
11.11.1 C3 Jian Company Detail
11.11.2 C3 Jian Business Overview
11.11.3 C3 Jian Microbiome Therapeutics Introduction
11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2019-2024)
11.11.5 C3 Jian Recent Development
11.12 Rebiotix
11.12.1 Rebiotix Company Detail
11.12.2 Rebiotix Business Overview
11.12.3 Rebiotix Microbiome Therapeutics Introduction
11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2019-2024)
11.12.5 Rebiotix Recent Development
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Detail
11.13.2 MicroBiome Therapeutics LLC Business Overview
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction
11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2019-2024)
11.13.5 MicroBiome Therapeutics LLC Recent Development
11.14 Metabiomics
11.14.1 Metabiomics Company Detail
11.14.2 Metabiomics Business Overview
11.14.3 Metabiomics Microbiome Therapeutics Introduction
11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2019-2024)
11.14.5 Metabiomics Recent Development
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Detail
11.15.2 Ritter Pharmaceuticals Business Overview
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction
11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2019-2024)
11.15.5 Ritter Pharmaceuticals Recent Development
11.16 Symberix
11.16.1 Symberix Company Detail
11.16.2 Symberix Business Overview
11.16.3 Symberix Microbiome Therapeutics Introduction
11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2019-2024)
11.16.5 Symberix Recent Development
11.17 OpenBiome
11.17.1 OpenBiome Company Detail
11.17.2 OpenBiome Business Overview
11.17.3 OpenBiome Microbiome Therapeutics Introduction
11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2019-2024)
11.17.5 OpenBiome Recent Development
11.18 Azitra
11.18.1 Azitra Company Detail
11.18.2 Azitra Business Overview
11.18.3 Azitra Microbiome Therapeutics Introduction
11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2019-2024)
11.18.5 Azitra Recent Development
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Detail
11.19.2 Symbiotix Biotherapies Business Overview
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction
11.19.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2019-2024)
11.19.5 Symbiotix Biotherapies Recent Development
11.20 Osel
11.20.1 Osel Company Detail
11.20.2 Osel Business Overview
11.20.3 Osel Microbiome Therapeutics Introduction
11.20.4 Osel Revenue in Microbiome Therapeutics Business (2019-2024)
11.20.5 Osel Recent Development
11.21 Metabogen
11.21.1 Metabogen Company Detail
11.21.2 Metabogen Business Overview
11.21.3 Metabogen Microbiome Therapeutics Introduction
11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2019-2024)
11.21.5 Metabogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Upper GIT
1.2.3 Lower GIT
1.3 Market by Application
1.3.1 Global Microbiome Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile Infection (CDI)
1.3.3 Inflammatory Bowel Disease (IBD)
1.3.4 Orphan Drug
1.3.5 Immuno-oncology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapeutics Market Perspective (2019-2030)
2.2 Microbiome Therapeutics Growth Trends by Region
2.2.1 Global Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbiome Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Microbiome Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Microbiome Therapeutics Market Dynamics
2.3.1 Microbiome Therapeutics Industry Trends
2.3.2 Microbiome Therapeutics Market Drivers
2.3.3 Microbiome Therapeutics Market Challenges
2.3.4 Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue
3.4 Global Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2023
3.5 Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapeutics Breakdown Data by Type
4.1 Global Microbiome Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2025-2030)
5 Microbiome Therapeutics Breakdown Data by Application
5.1 Global Microbiome Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microbiome Therapeutics Market Size (2019-2030)
6.2 North America Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbiome Therapeutics Market Size by Country (2019-2024)
6.4 North America Microbiome Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbiome Therapeutics Market Size (2019-2030)
7.2 Europe Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbiome Therapeutics Market Size by Country (2019-2024)
7.4 Europe Microbiome Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Microbiome Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbiome Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbiome Therapeutics Market Size (2019-2030)
9.2 Latin America Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbiome Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Microbiome Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Detail
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2019-2024)
11.1.5 Seres Therapeutics Recent Development
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Detail
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2019-2024)
11.2.5 Assembly Biosciences Recent Development
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Detail
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2019-2024)
11.3.5 Synthetic Biologics Recent Development
11.4 Interxon
11.4.1 Interxon Company Detail
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Therapeutics Introduction
11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2019-2024)
11.4.5 Interxon Recent Development
11.5 PureTech
11.5.1 PureTech Company Detail
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Therapeutics Introduction
11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2019-2024)
11.5.5 PureTech Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Detail
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Therapeutics Introduction
11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2019-2024)
11.6.5 Synlogic Recent Development
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Detail
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Therapeutics Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2019-2024)
11.7.5 Enterome BioScience Recent Development
11.8 4D Pharma
11.8.1 4D Pharma Company Detail
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Therapeutics Introduction
11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2019-2024)
11.8.5 4D Pharma Recent Development
11.9 Second Genome
11.9.1 Second Genome Company Detail
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Therapeutics Introduction
11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2019-2024)
11.9.5 Second Genome Recent Development
11.10 AOBiome
11.10.1 AOBiome Company Detail
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Therapeutics Introduction
11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2019-2024)
11.10.5 AOBiome Recent Development
11.11 C3 Jian
11.11.1 C3 Jian Company Detail
11.11.2 C3 Jian Business Overview
11.11.3 C3 Jian Microbiome Therapeutics Introduction
11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2019-2024)
11.11.5 C3 Jian Recent Development
11.12 Rebiotix
11.12.1 Rebiotix Company Detail
11.12.2 Rebiotix Business Overview
11.12.3 Rebiotix Microbiome Therapeutics Introduction
11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2019-2024)
11.12.5 Rebiotix Recent Development
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Detail
11.13.2 MicroBiome Therapeutics LLC Business Overview
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction
11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2019-2024)
11.13.5 MicroBiome Therapeutics LLC Recent Development
11.14 Metabiomics
11.14.1 Metabiomics Company Detail
11.14.2 Metabiomics Business Overview
11.14.3 Metabiomics Microbiome Therapeutics Introduction
11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2019-2024)
11.14.5 Metabiomics Recent Development
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Detail
11.15.2 Ritter Pharmaceuticals Business Overview
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction
11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2019-2024)
11.15.5 Ritter Pharmaceuticals Recent Development
11.16 Symberix
11.16.1 Symberix Company Detail
11.16.2 Symberix Business Overview
11.16.3 Symberix Microbiome Therapeutics Introduction
11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2019-2024)
11.16.5 Symberix Recent Development
11.17 OpenBiome
11.17.1 OpenBiome Company Detail
11.17.2 OpenBiome Business Overview
11.17.3 OpenBiome Microbiome Therapeutics Introduction
11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2019-2024)
11.17.5 OpenBiome Recent Development
11.18 Azitra
11.18.1 Azitra Company Detail
11.18.2 Azitra Business Overview
11.18.3 Azitra Microbiome Therapeutics Introduction
11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2019-2024)
11.18.5 Azitra Recent Development
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Detail
11.19.2 Symbiotix Biotherapies Business Overview
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Introduction
11.19.4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2019-2024)
11.19.5 Symbiotix Biotherapies Recent Development
11.20 Osel
11.20.1 Osel Company Detail
11.20.2 Osel Business Overview
11.20.3 Osel Microbiome Therapeutics Introduction
11.20.4 Osel Revenue in Microbiome Therapeutics Business (2019-2024)
11.20.5 Osel Recent Development
11.21 Metabogen
11.21.1 Metabogen Company Detail
11.21.2 Metabogen Business Overview
11.21.3 Metabogen Microbiome Therapeutics Introduction
11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2019-2024)
11.21.5 Metabogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 4. Global Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Microbiome Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 8. Global Microbiome Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 10. Microbiome Therapeutics Market Trends
Table 11. Microbiome Therapeutics Market Drivers
Table 12. Microbiome Therapeutics Market Challenges
Table 13. Microbiome Therapeutics Market Restraints
Table 14. Global Microbiome Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Microbiome Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2023)
Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Seres Therapeutics Company Detail
Table 47. Seres Therapeutics Business Overview
Table 48. Seres Therapeutics Microbiome Therapeutics Product
Table 49. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Seres Therapeutics Recent Development
Table 51. Assembly Biosciences Company Detail
Table 52. Assembly Biosciences Business Overview
Table 53. Assembly Biosciences Microbiome Therapeutics Product
Table 54. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Assembly Biosciences Recent Development
Table 56. Synthetic Biologics Company Detail
Table 57. Synthetic Biologics Business Overview
Table 58. Synthetic Biologics Microbiome Therapeutics Product
Table 59. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Synthetic Biologics Recent Development
Table 61. Interxon Company Detail
Table 62. Interxon Business Overview
Table 63. Interxon Microbiome Therapeutics Product
Table 64. Interxon Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Interxon Recent Development
Table 66. PureTech Company Detail
Table 67. PureTech Business Overview
Table 68. PureTech Microbiome Therapeutics Product
Table 69. PureTech Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 70. PureTech Recent Development
Table 71. Synlogic Company Detail
Table 72. Synlogic Business Overview
Table 73. Synlogic Microbiome Therapeutics Product
Table 74. Synlogic Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Synlogic Recent Development
Table 76. Enterome BioScience Company Detail
Table 77. Enterome BioScience Business Overview
Table 78. Enterome BioScience Microbiome Therapeutics Product
Table 79. Enterome BioScience Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Enterome BioScience Recent Development
Table 81. 4D Pharma Company Detail
Table 82. 4D Pharma Business Overview
Table 83. 4D Pharma Microbiome Therapeutics Product
Table 84. 4D Pharma Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 85. 4D Pharma Recent Development
Table 86. Second Genome Company Detail
Table 87. Second Genome Business Overview
Table 88. Second Genome Microbiome Therapeutics Product
Table 89. Second Genome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Second Genome Recent Development
Table 91. AOBiome Company Detail
Table 92. AOBiome Business Overview
Table 93. AOBiome Microbiome Therapeutics Product
Table 94. AOBiome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 95. AOBiome Recent Development
Table 96. C3 Jian Company Detail
Table 97. C3 Jian Business Overview
Table 98. C3 Jian Microbiome Therapeutics Product
Table 99. C3 Jian Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 100. C3 Jian Recent Development
Table 101. Rebiotix Company Detail
Table 102. Rebiotix Business Overview
Table 103. Rebiotix Microbiome Therapeutics Product
Table 104. Rebiotix Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Rebiotix Recent Development
Table 106. MicroBiome Therapeutics LLC Company Detail
Table 107. MicroBiome Therapeutics LLC Business Overview
Table 108. MicroBiome Therapeutics LLC Microbiome Therapeutics Product
Table 109. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 110. MicroBiome Therapeutics LLC Recent Development
Table 111. Metabiomics Company Detail
Table 112. Metabiomics Business Overview
Table 113. Metabiomics Microbiome Therapeutics Product
Table 114. Metabiomics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Metabiomics Recent Development
Table 116. Ritter Pharmaceuticals Company Detail
Table 117. Ritter Pharmaceuticals Business Overview
Table 118. Ritter Pharmaceuticals Microbiome Therapeutics Product
Table 119. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Ritter Pharmaceuticals Recent Development
Table 121. Symberix Company Detail
Table 122. Symberix Business Overview
Table 123. Symberix Microbiome Therapeutics Product
Table 124. Symberix Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 125. Symberix Recent Development
Table 126. OpenBiome Company Detail
Table 127. OpenBiome Business Overview
Table 128. OpenBiome Microbiome Therapeutics Product
Table 129. OpenBiome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 130. OpenBiome Recent Development
Table 131. Azitra Company Detail
Table 132. Azitra Business Overview
Table 133. Azitra Microbiome Therapeutics Product
Table 134. Azitra Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 135. Azitra Recent Development
Table 136. Symbiotix Biotherapies Company Detail
Table 137. Symbiotix Biotherapies Business Overview
Table 138. Symbiotix Biotherapies Microbiome Therapeutics Product
Table 139. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 140. Symbiotix Biotherapies Recent Development
Table 141. Osel Company Detail
Table 142. Osel Business Overview
Table 143. Osel Microbiome Therapeutics Product
Table 144. Osel Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 145. Osel Recent Development
Table 146. Metabogen Company Detail
Table 147. Metabogen Business Overview
Table 148. Metabogen Microbiome Therapeutics Product
Table 149. Metabogen Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 150. Metabogen Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Upper GIT Features
Figure 4. Lower GIT Features
Figure 5. Global Microbiome Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. C. difficile Infection (CDI) Case Studies
Figure 8. Inflammatory Bowel Disease (IBD) Case Studies
Figure 9. Orphan Drug Case Studies
Figure 10. Immuno-oncology Case Studies
Figure 11. Others Case Studies
Figure 12. Microbiome Therapeutics Report Years Considered
Figure 13. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Microbiome Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Microbiome Therapeutics Market Share by Players in 2023
Figure 17. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2023
Figure 19. North America Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 33. China Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 48. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 49. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 50. Interxon Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 51. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 52. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 53. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 54. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 55. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 56. AOBiome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 57. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 58. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 59. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 60. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 61. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 62. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 63. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 64. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 65. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 66. Osel Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 67. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Upper GIT
Table 3. Key Players of Lower GIT
Table 4. Global Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Microbiome Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Microbiome Therapeutics Market Share by Region (2019-2024)
Table 8. Global Microbiome Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Microbiome Therapeutics Market Share by Region (2025-2030)
Table 10. Microbiome Therapeutics Market Trends
Table 11. Microbiome Therapeutics Market Drivers
Table 12. Microbiome Therapeutics Market Challenges
Table 13. Microbiome Therapeutics Market Restraints
Table 14. Global Microbiome Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Microbiome Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2023)
Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Seres Therapeutics Company Detail
Table 47. Seres Therapeutics Business Overview
Table 48. Seres Therapeutics Microbiome Therapeutics Product
Table 49. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Seres Therapeutics Recent Development
Table 51. Assembly Biosciences Company Detail
Table 52. Assembly Biosciences Business Overview
Table 53. Assembly Biosciences Microbiome Therapeutics Product
Table 54. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Assembly Biosciences Recent Development
Table 56. Synthetic Biologics Company Detail
Table 57. Synthetic Biologics Business Overview
Table 58. Synthetic Biologics Microbiome Therapeutics Product
Table 59. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Synthetic Biologics Recent Development
Table 61. Interxon Company Detail
Table 62. Interxon Business Overview
Table 63. Interxon Microbiome Therapeutics Product
Table 64. Interxon Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Interxon Recent Development
Table 66. PureTech Company Detail
Table 67. PureTech Business Overview
Table 68. PureTech Microbiome Therapeutics Product
Table 69. PureTech Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 70. PureTech Recent Development
Table 71. Synlogic Company Detail
Table 72. Synlogic Business Overview
Table 73. Synlogic Microbiome Therapeutics Product
Table 74. Synlogic Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Synlogic Recent Development
Table 76. Enterome BioScience Company Detail
Table 77. Enterome BioScience Business Overview
Table 78. Enterome BioScience Microbiome Therapeutics Product
Table 79. Enterome BioScience Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Enterome BioScience Recent Development
Table 81. 4D Pharma Company Detail
Table 82. 4D Pharma Business Overview
Table 83. 4D Pharma Microbiome Therapeutics Product
Table 84. 4D Pharma Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 85. 4D Pharma Recent Development
Table 86. Second Genome Company Detail
Table 87. Second Genome Business Overview
Table 88. Second Genome Microbiome Therapeutics Product
Table 89. Second Genome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 90. Second Genome Recent Development
Table 91. AOBiome Company Detail
Table 92. AOBiome Business Overview
Table 93. AOBiome Microbiome Therapeutics Product
Table 94. AOBiome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 95. AOBiome Recent Development
Table 96. C3 Jian Company Detail
Table 97. C3 Jian Business Overview
Table 98. C3 Jian Microbiome Therapeutics Product
Table 99. C3 Jian Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 100. C3 Jian Recent Development
Table 101. Rebiotix Company Detail
Table 102. Rebiotix Business Overview
Table 103. Rebiotix Microbiome Therapeutics Product
Table 104. Rebiotix Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 105. Rebiotix Recent Development
Table 106. MicroBiome Therapeutics LLC Company Detail
Table 107. MicroBiome Therapeutics LLC Business Overview
Table 108. MicroBiome Therapeutics LLC Microbiome Therapeutics Product
Table 109. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 110. MicroBiome Therapeutics LLC Recent Development
Table 111. Metabiomics Company Detail
Table 112. Metabiomics Business Overview
Table 113. Metabiomics Microbiome Therapeutics Product
Table 114. Metabiomics Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 115. Metabiomics Recent Development
Table 116. Ritter Pharmaceuticals Company Detail
Table 117. Ritter Pharmaceuticals Business Overview
Table 118. Ritter Pharmaceuticals Microbiome Therapeutics Product
Table 119. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 120. Ritter Pharmaceuticals Recent Development
Table 121. Symberix Company Detail
Table 122. Symberix Business Overview
Table 123. Symberix Microbiome Therapeutics Product
Table 124. Symberix Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 125. Symberix Recent Development
Table 126. OpenBiome Company Detail
Table 127. OpenBiome Business Overview
Table 128. OpenBiome Microbiome Therapeutics Product
Table 129. OpenBiome Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 130. OpenBiome Recent Development
Table 131. Azitra Company Detail
Table 132. Azitra Business Overview
Table 133. Azitra Microbiome Therapeutics Product
Table 134. Azitra Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 135. Azitra Recent Development
Table 136. Symbiotix Biotherapies Company Detail
Table 137. Symbiotix Biotherapies Business Overview
Table 138. Symbiotix Biotherapies Microbiome Therapeutics Product
Table 139. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 140. Symbiotix Biotherapies Recent Development
Table 141. Osel Company Detail
Table 142. Osel Business Overview
Table 143. Osel Microbiome Therapeutics Product
Table 144. Osel Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 145. Osel Recent Development
Table 146. Metabogen Company Detail
Table 147. Metabogen Business Overview
Table 148. Metabogen Microbiome Therapeutics Product
Table 149. Metabogen Revenue in Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 150. Metabogen Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Upper GIT Features
Figure 4. Lower GIT Features
Figure 5. Global Microbiome Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. C. difficile Infection (CDI) Case Studies
Figure 8. Inflammatory Bowel Disease (IBD) Case Studies
Figure 9. Orphan Drug Case Studies
Figure 10. Immuno-oncology Case Studies
Figure 11. Others Case Studies
Figure 12. Microbiome Therapeutics Report Years Considered
Figure 13. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Microbiome Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Microbiome Therapeutics Market Share by Players in 2023
Figure 17. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2023
Figure 19. North America Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 33. China Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 48. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 49. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 50. Interxon Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 51. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 52. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 53. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 54. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 55. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 56. AOBiome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 57. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 58. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 59. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 60. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 61. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 62. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 63. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 64. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 65. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 66. Osel Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 67. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232